US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology Industry Research & Market Reports

3  4  5  6    8    10  11  12  
XDx, Inc. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... patient outcomes. It commercializes AlloMap molecular expression testing, which aids clinicians in identifying heart transplant recipients with stable graft function. XDx applies genomics and bioinformatics technology to develop molecular diagnostic assays based on gene expression ...  |  read more...
USD 750
MacroGenics, Inc.
6/26/2014 | published by: SGA ExecutiveTracker
... City, State & Zip), US HQ Phone Number & Company Website Address, Ticker Symbol, Most Recent Revenues Reported, Number of Employees and Industry. SGA Business Lists do not include direct-dial phone numbers for all executives ...  |  read more...
USD 34
Acorda Therapeutics, Inc.
6/26/2014 | published by: SGA ExecutiveTracker
... City, State & Zip), US HQ Phone Number & Company Website Address, Ticker Symbol, Most Recent Revenues Reported, Number of Employees and Industry. SGA Business Lists do not include direct-dial phone numbers for all executives ...  |  read more...
USD 35
Promega Corporation
6/26/2014 | published by: SGA ExecutiveTracker
... City, State & Zip), US HQ Phone Number & Company Website Address, Ticker Symbol, Most Recent Revenues Reported, Number of Employees and Industry. SGA Business Lists do not include direct-dial phone numbers for all executives ...  |  read more...
USD 42
Novartis Consumer Health, Inc.
6/26/2014 | published by: SGA ExecutiveTracker
... City, State & Zip), US HQ Phone Number & Company Website Address, Ticker Symbol, Most Recent Revenues Reported, Number of Employees and Industry. SGA Business Lists do not include direct-dial phone numbers for all executives ...  |  read more...
USD 45
Global Markets for Bioengineered Protein Drugs
8/1/2014 | published by: BCC Research
... grow to about $222.7 billion in 2019, a compound annual growth rate (CAGR) of 7.2% from 2014 through 2019. This report provides: An overview of the global market for bioengineered protein drugs. Analyses of global ...  |  read more...
USD 6,650
Albany Molecular Research, Inc.
6/26/2014 | published by: SGA ExecutiveTracker
... City, State & Zip), US HQ Phone Number & Company Website Address, Ticker Symbol, Most Recent Revenues Reported, Number of Employees and Industry. SGA Business Lists do not include direct-dial phone numbers for all executives ...  |  read more...
USD 65
Covance Inc.
6/26/2014 | published by: SGA ExecutiveTracker
... City, State & Zip), US HQ Phone Number & Company Website Address, Ticker Symbol, Most Recent Revenues Reported, Number of Employees and Industry. SGA Business Lists do not include direct-dial phone numbers for all executives ...  |  read more...
USD 113
InterMune, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' InterMune, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Celgene Corporation
6/26/2014 | published by: SGA ExecutiveTracker
... City, State & Zip), US HQ Phone Number & Company Website Address, Ticker Symbol, Most Recent Revenues Reported, Number of Employees and Industry. SGA Business Lists do not include direct-dial phone numbers for all executives ...  |  read more...
USD 153
The Latest Sales Figures in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... global pharmacuetical companies to progressive biotech companies. The analysis leverages the power of BioSeeker's 1stOncology intelligence which combines company disclosed product sales and detailed drug development information. The results is not only a unique insight ...  |  read more...
USD 4,478
Global Markets for Nanoparticle Size Analysis Instrumentation in the Life Sciences
8/1/2014 | published by: BCC Research
... in 2014 and about $7.8 billion by 2019, a compound annual growth rate (CAGR) of 5.7% for the five-year period, 2014 to 2019. This report provides: An overview of the global market for particle size ...  |  read more...
USD 6,650
Intercell AG : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Intercell AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Atrium Innovations, Inc. (formerly Atrium Biotechnologies, Inc.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Atrium Innovations, Inc. (formerly Atrium Biotechnologies, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances ...  |  read more...
USD 350
Marina Biotech, Inc. (formerly MDRNA, Inc.) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Marina Biotech, Inc. (formerly MDRNA, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...  |  read more...
USD 350
Verenium Corporation (Formerly Diversa Corporation) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Verenium Corporation (Formerly Diversa Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes ...  |  read more...
USD 350
Cytori Therapeutics, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Cytori Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Asuragen, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Asuragen, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
PolyTherics Limited : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' PolyTherics Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Life Technologies Corporation (formerly Invitrogen Corporation) : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Life Technologies Corporation (formerly Invitrogen Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...  |  read more...
USD 350
Senesco Technologies, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Senesco Technologies, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Epigenetic R&D, Therapies and Diagnostics: Industry and Market Prospects 2014-2024
6/25/2014 | published by: Visiongain
... medicines? Now get the latest analysis for that industry. There you explore developments (R&D), results, opportunities, trends and revenue forecasts. Visiongain’s updated report shows you what’s possible for those drugs, diagnostic tests and related technology. ...  |  read more...
USD 3,004
Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market
7/14/2014 | published by: GBI Research
... “Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market”, which provides in-depth analysis of the critical care market in the US, UK, France, ...  |  read more...
USD 4,995
Sinovac Biotech Ltd. - Product Pipeline Review - 2014
7/22/2014 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Sinovac Biotech Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Biotech Business August 2014
8/1/2014 | published by: Worldwide Videotex
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline.  |  read more...
USD 25
3  4  5  6    8    10  11  12